CompletedPHASE2, PHASE3NCT00168103
Human C1 Esterase Inhibitor (C1-INH) in Subjects With Acute Abdominal or Facial Hereditary Angioedema (HAE) Attacks
Studying Hereditary angioedema
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- CSL Behring
- Principal Investigator
- Program Director, Clinical R&DCSL Behring
- Intervention
- C1 Esterase Inhibitor(biological)
- Enrollment
- 126 enrolled
- Eligibility
- 6 years · All sexes
- Timeline
- 2005 – 2007
Study locations (30)
- Study Site, Granada Hills, California, United States
- Study Site, Weston, Florida, United States
- Study Site, Atlanta, Georgia, United States
- Study Site, Idaho Falls, Idaho, United States
- Study Site, Chicago, Illinois, United States
- Study Site, Shreveport, Louisiana, United States
- Study Site, Boston, Massachusetts, United States
- Study Site, Plymouth, Minnesota, United States
- Study Site, Omaha, Nebraska, United States
- Study Site, The Bronx, New York, United States
- Study Site, Cincinnati, Ohio, United States
- Study Site, Tulsa, Oklahoma, United States
- Study Site, Eugene, Oregon, United States
- Study Site, Hershey, Pennsylvania, United States
- Study Site, Rapid City, South Dakota, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00168103 on ClinicalTrials.govOther trials for Hereditary angioedema
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT07298447Donidalorsen Treatment in Children With Hereditary AngioedemaIonis Pharmaceuticals, Inc.
- RECRUITINGNANCT07559630Single-center Randomized Controlled Trial of Rectal Arterial Embolization vs Band Ligation for the Treatment of Internal hemOrrhoidSJessica K. Stewart, MD
- RECRUITINGPHASE3NCT07428499Phase 3 Extension Study of ADX-324 in Participants With Hereditary Angioedema (HAE)ADARx Pharmaceuticals, Inc.
- RECRUITINGNANCT07251933A Study of Lanadelumab in Children With Hereditary Angioedema (HAE) in Multiple CountriesTakeda
- ENROLLING BY INVITATIONPHASE3NCT07204938A Long-Term Study of Navenibart in Participants With Hereditary AngioedemaAstria Therapeutics, Inc.
- RECRUITINGPHASE3NCT06960213STOP-HAE: A Phase 3 Study of ADX-324 in HAEADARx Pharmaceuticals, Inc.
- RECRUITINGNANCT07001280A Study Investigating the Effectiveness and Safety of Garadacimab for Treating Patients With Hereditary Angioedema (HAE)CSL Behring
- RECRUITINGPHASE3NCT06842823A Study of Navenibart in Participants With Hereditary AngioedemaAstria Therapeutics, Inc.